Cited by 84

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Metal nanoparticles as a potential technique for the diagnosis and treatment of gastrointestinal cancer: a comprehensive review

Roshani, Mohammad, Rezaian-Isfahni, Arya, Lotfalizadeh, Mohammad Hassan, Khassafi, Negar, Abadi, Mohammad Hassan Jafari Najaf, Nejati, Majid·2023·Cancer Cell International

Abstract

Gastrointestinal (GI) cancer is a major health problem worldwide, and current diagnostic and therapeutic approaches are often inadequate. Various metallic nanoparticles (MNPs) have been widely studied for several biomedical applications, including cancer. They may potentially overcome the challenges associated with conventional chemotherapy and significantly impact the overall survival of GI cancer patients. Functionalized MNPs with targeted ligands provide more efficient localization of tumor energy deposition, better solubility and stability, and specific targeting properties. In addition to enhanced therapeutic efficacy, MNPs are also a diagnostic tool for molecular imaging of malignant lesions, enabling non-invasive imaging or detection of tumor-specific or tumor-associated antigens. MNP-based therapeutic systems enable simultaneous stability and solubility of encapsulated drugs and regulate the delivery of therapeutic agents directly to tumor cells, which improves therapeutic efficacy and minimizes drug toxicity and leakage into normal cells. However, metal nanoparticles have been shown to have a cytotoxic effect on cells in vitro. This can be a concern when using metal nanoparticles for cancer treatment, as they may also kill healthy cells in addition to cancer cells. In this review, we provide an overview of the current state of the field, including preparation methods of MNPs, clinical applications, and advances in their use in targeted GI cancer therapy, as well as the advantages and limitations of using metal nanoparticles for the diagnosis and treatment of gastrointestinal cancer such as potential toxicity. We also discuss potential future directions and areas for further research, including the development of novel MNP-based approaches and the optimization of existing approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12935-023-03115-1

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 1 references

Research works printed but not linked: 238

  1. Lau HCH, et al. Organoid models of gastrointestinal cancers in basic and translational research. Nat Rev Gastroenterol Hepatol. 2020;17(4):203–22. · DOI
  2. Roshani M, et al. Exosomal long non-coding RNAs: novel molecules in gastrointestinal cancers’ progression and diagnosis. Front Oncol. 2022;12:1014949. · DOI
  3. Davoodvandi A, et al. An update on the effects of Probiotics on gastrointestinal cancers. Front Pharmacol. 2021;12:680400. · DOI
  4. Dashti F, et al. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Mol Ther Nucleic Acids. 2021;26:892–926. · DOI
  5. Banikazemi Z, et al. Coumarins and gastrointestinal Cancer: a new therapeutic option? Front Oncol. 2021;11:752784. · DOI
  6. Davoodvandi A, et al. Antimetastatic effects of Curcumin in oral and gastrointestinal cancers. Front Pharmacol. 2021;12:668567. · DOI
  7. Fallah M, et al. Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer. Biomed Pharmacother. 2021;142:112024. · DOI
  8. Razavi ZS, et al. Angiogenesis-related non-coding RNAs and gastrointestinal cancer. Mol Ther Oncolytics. 2021;21:220–41. · DOI
  9. Sarvizadeh M, et al. Allicin and Digestive System cancers: from Chemical structure to its Therapeutic opportunities. Front Oncol. 2021;11:650256. · DOI
  10. Shafabakhsh R, et al. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance. Cancer Gene Ther. 2021;28(12):1229–55. · DOI
  11. Ashrafizadeh M, et al. Sensing the scent of death: modulation of microRNAs by Curcumin in gastrointestinal cancers. Pharmacol Res. 2020;160:105199. · DOI
  12. Pourhanifeh MH, et al. Autophagy-related microRNAs: possible regulatory roles and therapeutic potential in and gastrointestinal cancers. Pharmacol Res. 2020;161:105133. · DOI
  13. Roshani M, et al. Applications of resveratrol in the treatment of gastrointestinal cancer. Biomed Pharmacother. 2022;153:113274. · DOI
  14. Sitarz R, et al. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–48. · DOI
  15. Parikh AR, et al. Serial ctDNA monitoring to predict response to systemic therapy in metastatic gastrointestinal cancers. Clin Cancer Res. 2020;26(8):1877–85. · DOI
  16. Zhao Y, et al. Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers. Semin Cancer Biol. 2020;60:334–43. · DOI
  17. Chidambaram M, Manavalan R, Kathiresan K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci. 2011;14(1):67–77. · DOI
  18. Marin JJ, et al. Importance and limitations of chemotherapy among the available treatments for gastrointestinal tumours. Anticancer Agents Med Chem. 2009;9(2):162–84. · DOI
  19. Sack M, et al. Combination of conventional chemotherapeutics with redox-active cerium oxide nanoparticles–a novel aspect in cancer therapy. Mol Cancer Ther. 2014;13(7):1740–9. · DOI
  20. Pourmortazavi SM, et al. Taguchi robust design to optimize synthesis of lead oxalate nano-disks. Mater Sci Semiconduct Process. 2013;16(1):131–7. · DOI
  21. Rahimi-Nasrabadi M, et al. Assessment of supercapacitive performance of europium tungstate nanoparticles prepared via hydrothermal method. J Mater Sci: Mater Electron. 2017;28(17):12391–8.
  22. Rahimi-Nasrabadi M, Ahmadi F, Eghbali-Arani M. Simple morphology-controlled fabrication of CdTiO3 nanoparticles with the aid of different capping agents. J Mater Sci: Mater Electron. 2016;27(12):13294–9.
  23. Sohouli E, et al. A glassy carbon electrode modified with carbon nanoonions for electrochemical determination of fentanyl. Mater Sci Engineering: C. 2020;110:110684. · DOI
  24. Rahimi-Nasrabadi M, et al. Fabrication, characterization and photochemical activity of ytterbium carbonate and ytterbium oxide nanoparticles. J Mater Sci: Mater Electron. 2017;28(13):9478–88.
  25. Sarani M, et al. α-Fe(2) O(3) @Ag and Fe(3) O(4) @Ag Core-Shell nanoparticles: green synthesis, magnetic properties and cytotoxic performance. ChemistryOpen. 2023;12(6):e202200250. · DOI
  26. Liu Y, et al. Biodegradable and Cytocompatible Hydrogel Coating with antibacterial activity for the Prevention of Implant-Associated Infection. ACS Appl Mater Interfaces. 2023;15(9):11507–19. · DOI
  27. Wang Y, et al. Surface-functionalized design of blood-contacting biomaterials for preventing coagulation and promoting hemostasis. Friction. 2023;11(8):1371–94. · DOI
  28. Lan J-S, et al. Tumor-specific carrier-free nanodrugs with GSH depletion and enhanced ROS generation for endogenous synergistic anti-tumor by a chemotherapy-photodynamic therapy. Chem Eng J. 2021;407:127212. · DOI
  29. Kumari M, et al. Toxicity study of cerium oxide nanoparticles in human neuroblastoma cells. Int J Toxicol. 2014;33(2):86–97. · DOI
  30. Gandomi F, et al. Simple synthesis and characterization of Li0. 5Fe2. 5O4, LiMg0. 5Fe2O4 and LiNi0. 5Fe2O4, and investigation of their photocatalytic and anticancer properties on hela cells line. J Mater Sci: Mater Electron. 2019;30(22):19691–702.
  31. Sobhani-Nasab A, et al. Synergetic effect of graphene oxide and C3N4 as co-catalyst for enhanced photocatalytic performance of dyes on Yb2 (MoO4) 3/YbMoO4 nanocomposite. Ceram Int. 2019;45(14):17847–58. · DOI
  32. Sohouli E, et al. A noble electrochemical sensor based on TiO2@ CuO-N-rGO and poly (L-cysteine) nanocomposite applicable for trace analysis of flunitrazepam. Mater Sci Engineering: C. 2020;117:111300. · DOI
  33. Rahimi-Nasrabadi M, et al. Samarium carbonate and samarium oxide; synthesis, characterization and evaluation of the photo-catalytic behavior. J Mater Sci: Mater Electron. 2017;28(7):5574–83.
  34. Rahimi-Nasrabadi M, Ahmadi F, Eghbali-Arani M. Different morphologies fabrication of NiAl2O4 nanostructures with the aid of new template and its photocatalyst application. J Mater Sci: Mater Electron. 2017;28(3):2415–20.
  35. Florence AT. Targeting nanoparticles: the constraints of physical laws and physical barriers. J Control Release. 2012;164(2):115–24. · DOI
  36. Peer D, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751–60. · DOI · Paper page
  37. Akbari M, et al. CdTe quantum dots prepared using herbal species and microorganisms and their anti-cancer, drug delivery and antibacterial applications; a review. Ceram Int. 2020;46(8):9979–89. · DOI
  38. Hafezi M, et al. Cur-loaded ZnFe2O4@ mZnO@ N-GQDs biocompatible nano-carriers for smart and controlled targeted drug delivery with pH-triggered and ultrasound irradiation. J Mol Liq. 2021;322:114875. · DOI
  39. Rostami M, et al. The ZnFe 2 O 4@ mZnO–N/RGO nano-composite as a carrier and an intelligent releaser drug with dual pH-and ultrasound-triggered control. New J Chem. 2021;45(9):4280–91. · DOI
  40. Rostami M, et al. Cur-loaded magnetic ZnFe2O4@ mZnO-Ox-pg-C3N4 composites as dual pH-and ultrasound responsive nano-carriers for controlled and targeted cancer chemotherapy. Mater Chem Phys. 2021;271:124863. · DOI
  41. Jafari H, et al. Highly efficient sunitinib release from pH-responsive mHPMC@ Chitosan core-shell nanoparticles. Carbohydr Polym. 2021;258:117719. · DOI
  42. Xu JJ, et al. Metal nanoparticles as a promising technology in targeted cancer treatment. Drug Deliv. 2022;29(1):664–78. · DOI
  43. Baptista P, et al. Gold nanoparticles for the development of clinical diagnosis methods. Anal Bioanal Chem. 2008;391(3):943–50. · DOI
  44. Huang X, et al. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomed (Lond). 2007;2(5):681–93. · DOI
  45. Hainfeld JF, et al. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol. 2008;60(8):977–85. · DOI
  46. Aldahhan R, Almohazey D, Khan FA. Emerging trends in the application of gold nanoformulations in colon Cancer diagnosis and treatment. Semin Cancer Biol; 2021. · DOI
  47. Avedisian CT, et al. Nanoparticles for cancer treatment: role of heat transfer. Ann N Y Acad Sci. 2009;1161:62–73. · DOI
  48. Day ES, Morton JG, West JL. Nanopart Therm cancer Therapy 2009. · DOI
  49. Park SY, et al. Anti-metastatic effect of gold nanoparticle-conjugated Maclura tricuspidata Extract on Human Hepatocellular Carcinoma cells. Int J Nanomedicine. 2020;15:5317–31. · DOI
  50. Sau TK, et al. Properties and applications of colloidal nonspherical noble metal nanoparticles. Adv Mater. 2010;22(16):1805–25. · DOI
  51. Jones MR, et al. Plasmonically controlled nucleic acid dehybridization with gold nanoprisms. ChemPhysChem. 2009;10(9–10):1461–5. · DOI
  52. Sperling RA, et al. Biological applications of gold nanoparticles. Chem Soc Rev. 2008;37(9):1896–908. · DOI
  53. Lee K-S, El-Sayed MA. Gold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal composition. J Phys Chem B. 2006;110(39):19220–5. · DOI
  54. Jain PK, et al. Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res. 2008;41(12):1578–86. · DOI
  55. M KR, Balakrishnan J. Investigating the thermal transport in gold decorated graphene by opto-thermal Raman technique. Nanotechnology, 2022. 33(13). · DOI
  56. Arnold M, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335–49. e15. · DOI · Paper page
  57. Shi J, Qu Y-P, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterology: WJG. 2014;20(38):13804. · DOI
  58. Muls AC, et al. Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists. Frontline Gastroenterol. 2013;4(1):57–68. · DOI
  59. Gong P, et al. Preparation and antibacterial activity of Fe3O4@ Ag nanoparticles. Nanotechnology. 2007;18(28):285604. · DOI
  60. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76–83. · DOI
  61. Rahimi-Nasrabadi M, et al. Green synthesis of silver nanoparticles using Eucalyptus leucoxylon leaves extract and evaluating the antioxidant activities of extract. Nat Prod Res. 2014;28(22):1964–9. · DOI
  62. Pourmortazavi SM, et al. Procedure optimization for green synthesis of silver nanoparticles by aqueous extract of Eucalyptus oleosa. Spectrochim Acta Part A Mol Biomol Spectrosc. 2015;136:1249–54. · DOI
  63. Djahaniani H, et al. Facile synthesis of silver nanoparticles using Tribulus Longipetalus extract and their antioxidant and antibacterial activities. Int J Food Prop. 2017;20(4):922–30. · DOI
  64. Sharma VK, Yngard RA, Lin Y. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interface Sci. 2009;145(1–2):83–96. · DOI
  65. Yesilot S, Aydin C. Silver nanoparticles; a new hope in cancer therapy? Eastern J Med. 2019;24(1):111–6. · DOI
  66. Baban DF, Seymour LW. Control of tumour vascular permeability. Adv Drug Deliv Rev. 1998;34(1):109–19. · DOI
  67. Tomar A, Garg G. Short review on application of gold nanoparticles. Global J Pharmacol. 2013;7(1):34–8.
  68. Curry T, et al. Multifunctional theranostic gold nanoparticles for targeted CT imaging and photothermal therapy. Contrast Media Mol Imaging. 2014;9(1):53–61. · DOI
  69. Mohl M, et al. Formation of CuPd and CuPt bimetallic nanotubes by galvanic replacement reaction. J Phys Chem C. 2011;115(19):9403–9. · DOI
  70. Fan T-X, Chow S-K, Zhang D. Biomorphic mineralization: from biology to materials. Prog Mater Sci. 2009;54(5):542–659. · DOI
  71. Bisht N, Phalswal P, Khanna PK. Selenium nanoparticles: a review on synthesis and biomedical applications. Mater Adv. 2022;3(3):1415–31. · DOI
  72. Phan TTV, et al. An up-to-date review on biomedical applications of palladium nanoparticles. Nanomaterials. 2019;10(1):66. · DOI
  73. Ziental D, et al. Titanium dioxide nanoparticles: prospects and applications in medicine. Nanomaterials. 2020;10(2):387. · DOI · Paper page
  74. Jiang J, Pi J, Cai J. The advancing of zinc oxide nanoparticles for biomedical applications Bioinorganic chemistry and applications, 2018. 2018. · DOI
  75. Prasad PR, Kanchi S, Naidoo E. -vitro evaluation of copper nanoparticles cytotoxicity on Prostate cancer cell lines and their antioxidant, sensing and catalytic activity: one-pot green approach. J Photochem Photobiol B. 2016;161:375–82. · DOI
  76. Solairaj D, Rameshthangam P, Arunachalam G. Anticancer activity of silver and copper embedded chitin nanocomposites against human Breast cancer (MCF-7) cells. Int J Biol Macromol. 2017;105:608–19. · DOI
  77. Li X et al. Biosynthesis of nanoparticles by microorganisms and their applications Journal of Nanomaterials, 2011. 2011. · DOI · Paper page
  78. Pacioni NL, et al. Synthetic routes for the preparation of silver nanoparticles, in silver nanoparticle applications. Springer; 2015. pp. 13–46. · DOI
  79. Rajput N. Methods of preparation of nanoparticles-a review. Int J Adv Eng Technol. 2015;7(6):1806.
  80. Horikoshi S, Serpone N. Microwaves in nanoparticle synthesis: fundamentals and applications. John Wiley & Sons; 2013. · DOI
  81. Ahmed S, et al. A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: a green expertise. J Adv Res. 2016;7(1):17–28. · DOI
  82. Swathy B. A review on metallic silver nanoparticles. IOSR J Pharm. 2014;4(7):2250–3013.
  83. Rahimi-Nasrabadi M, et al. Preparation of Co2TiO4/CoTiO3/Polyaniline ternary nano-hybrids for enhanced destruction of agriculture Poison and organic dyes under visible-light irradiation. J Mater Sci: Mater Electron. 2019;30(17):15854–68.
  84. Ghanbari MH, et al. A nanocomposite prepared from reduced graphene oxide, gold nanoparticles and poly (2-amino-5-mercapto-1, 3, 4-thiadiazole) for use in an electrochemical sensor for doxorubicin. Microchim Acta. 2019;186(9):1–10. · DOI
  85. Rahimi-Nasrabadi M, et al. Synthesis of nano-structured lanthanum tungstates photocatalysts. J Mater Sci: Mater Electron. 2017;28(11):7600–8.
  86. Mirsadeghi S, et al. Photocatalytic reduction of imatinib mesylate and imipenem on electrochemical synthesized Al2W3O12 nanoparticle: optimization, investigation of electrocatalytic and antimicrobial activity. Colloids Surf a. 2020;586:124254. · DOI
  87. Vijayakumar M, et al. Biosynthesis, characterisation and anti-bacterial effect of plant-mediated silver nanoparticles using Artemisia Nilagirica. Ind Crops Prod. 2013;41:235–40. · DOI
  88. Rahimi-Nasrabadi M. Effects of amino acid capping-agents on the size and morphology and photocatalytic properties of BNCTO nanostructures. J Mater Sci: Mater Electron. 2017;28(9):6373–8.
  89. Adib K, et al. Sonochemical synthesis of Ag2WO4/RGO-based nanocomposite as a potential material for supercapacitors electrodes. Ceram Int. 2021;47(10):14075–86. · DOI
  90. Jamkhande PG, et al. Metal nanoparticles synthesis: an overview on methods of preparation, advantages and disadvantages, and applications. J Drug Deliv Sci Technol. 2019;53:101174. · DOI
  91. Xu J-J, et al. Metal nanoparticles as a promising technology in targeted cancer treatment. Drug Delivery. 2022;29(1):664–78. · DOI
  92. Liu J, et al. A self-assembled platform based on branched DNA for sgRNA/Cas9/antisense delivery. J Am Chem Soc. 2019;141(48):19032–7. · DOI
  93. Fernandes AR, Baptista PV. Gene silencing using multifunctionalized gold nanoparticles for cancer therapy. Cancer Nanotechnology. Springer; 2017. pp. 319–36. · DOI
  94. Fernandes AR, Baptista PV. Gene silencing using multifunctionalized gold nanoparticles for cancer therapy. Cancer Nanotechnology: Methods and Protocols, 2017: p. 319–36. · DOI
  95. Jain N, et al. Green synthesized plant-based silver nanoparticles: therapeutic prospective for anticancer and antiviral activity. Micro and Nano Systems Letters. 2021;9(1):5. · DOI
  96. Sivakumar P, et al. Photo-triggered antibacterial and anticancer activities of zinc oxide nanoparticles. J Mater Chem B. 2018;6(30):4852–71. · DOI
  97. Li C, et al. Combined bortezomib-based chemotherapy and p53 gene therapy using hollow mesoporous silica nanospheres for p53 mutant non-small cell Lung cancer treatment. Biomater Sci. 2016;5(1):77–88. · DOI
  98. Li S, et al. Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system. Theranostics. 2018;8(10):2621–33. · DOI
  99. Mahmoud MA. Plasmon Resonance Hybridization of Gold Nanospheres and Palladium nanoshells Combined in a Rattle structure. J Phys Chem Lett. 2014;5(15):2594–600. · DOI
  100. Zhang J, et al. Photothermal and gene therapy combined with immunotherapy to gastric cancer by the gold nanoshell-based system. J Nanobiotechnol. 2019;17(1):80. · DOI
  101. Yun Z, et al. Biosynthesis of gold nanoparticles using Vetex negundo and evaluation of pro-apoptotic effect on human gastric cancer cell lines. J Photochem Photobiol B. 2020;203:111749. · DOI
  102. Hosseinalizadeh H, Mahmoodpour M, Ebrahimi A. The role of cell-free circulating DNA in the diagnosis and prognosis of Breast Cancer. Annals of Cancer Research and Therapy. 2021;29(2):169–77. · DOI
  103. Karuppaiya P, Satheeshkumar E, Tsay HS. Biogenic synthesis of silver nanoparticles using rhizome extract of Dysosma pleiantha and its antiproliferative effect against breast and human gastric cancer cells. Mol Biol Rep. 2019;46(5):4725–34. · DOI
  104. Mousavi B, Tafvizi F, Zaker S, Bostanabad. Green synthesis of silver nanoparticles using Artemisia turcomanica leaf extract and the study of anti-cancer effect and apoptosis induction on gastric cancer cell line (AGS). Artif Cells Nanomed Biotechnol. 2018;46(sup1):499–510. · DOI
  105. Wang R, et al. Biologically synthesized black ginger-selenium nanoparticle induces apoptosis and autophagy of AGS gastric cancer cells by suppressing the PI3K/Akt/mTOR signaling pathway. J Nanobiotechnol. 2022;20(1):1–20. · DOI
  106. Tang Q, et al. Synthesis and characterization of zinc oxide nanoparticles from Morus nigra and its anticancer activity of AGS gastric cancer cells. J Photochem Photobiol B. 2020;202:111698. · DOI
  107. Nasr R, et al. Induction of apoptosis and inhibition of invasion in gastric cancer cells by titanium dioxide nanoparticles. Oman Med J. 2018;33(2):111. · DOI
  108. Kubota T, et al. HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer. Nanomedicine. 2018;14(6):1919–29. · DOI
  109. Zhang Y, et al. Synthesis and application of AS1411-Functionalized gold nanoparticles for targeted therapy of gastric Cancer. ACS Omega. 2020;5(48):31227–33. · DOI
  110. Marchant MJ et al. Gold@Silica nanoparticles functionalized with oligonucleotides: a Prominent Tool for the detection of the Methylated Reprimo Gene in Gastric Cancer by Dynamic Light Scattering. Nanomaterials (Basel), 2019. 9(9). · DOI
  111. Kim YJ, et al. Development of Lactobacillus kimchicus DCY51(T)-mediated gold nanoparticles for delivery of ginsenoside compound K: in vitro photothermal effects and apoptosis detection in cancer cells. Artif Cells Nanomed Biotechnol. 2019;47(1):30–44. · DOI
  112. Li YF, Zhang HT, Xin L. Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric Tumor growth via targeting CD44 + gastric cancer cells. 2018. 144(8): p. 1463–73. · DOI
  113. Wang X, et al. In situ decorated au NPs on chitosan-encapsulated Fe(3)O(4)-NH(2) NPs as magnetic nanocomposite: investigation of its anti-colon carcinoma, anti-gastric cancer and anti-pancreatic cancer. Int J Biol Macromol. 2021;171:198–207. · DOI
  114. Wang R et al. Gold nanoparticles prepared with Phyllanthus emblica Fruit Extract and Bifidobacterium animalis subsp. lactis can induce apoptosis via mitochondrial impairment with inhibition of Autophagy in the human gastric Carcinoma Cell Line AGS. 2021. 11(5). · DOI
  115. Salehi S, et al. Phytosynthesis of silver nanoparticles using Artemisia marschalliana Sprengel aerial part extract and assessment of their antioxidant, anticancer, and antibacterial properties. Int J Nanomedicine. 2016;11:1835–46.
  116. Hashemi Z, et al. Green Synthesized Silver nanoparticles using Feijoa Sellowiana Leaf Extract, evaluation of their Antibacterial, Anticancer and antioxidant activities. Iran J Pharm Res. 2020;19(4):306–20.
  117. Chen Y, et al. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo. J Gastroenterol. 2013;48(7):809–21. · DOI
  118. Sawamura T, et al. The Effect of Coatings on the Affinity of Lanthanide nanoparticles to MKN45 and HeLa Cancer cells and improvement in photodynamic therapy efficiency. Int J Mol Sci. 2015;16(9):22415–24. · DOI
  119. Wu Y, et al. Intrinsic effects of gold nanoparticles on proliferation and invasion activity in SGC-7901 cells. Oncol Rep. 2016;35(3):1457–62. · DOI
  120. Huang P, et al. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials. 2011;32(36):9796–809. · DOI
  121. Chaturvedi VK et al. Pleurotus sajor-caju-mediated synthesis of silver and gold nanoparticles active against Colon Cancer cell lines: a new era of Herbonanoceutics. Molecules, 2020. 25(13). · DOI
  122. Arya M et al. In vitro and in silico molecular interaction of multiphase nanoparticles containing inositol hexaphosphate and jacalin: therapeutic potential against colon Cancer cells (HCT-15). J Cell Physiol, 2019. · DOI
  123. Go G et al. PrPC Aptamer Conjugated–Gold Nanoparticles for Targeted Delivery of Doxorubicin to Colorectal Cancer Cells International Journal of Molecular Sciences, 2021. 22(4): p. 1976. · DOI
  124. Leve F, et al. Gold nanoparticles regulate tight junctions and improve cetuximab effect in colon Cancer cells. Nanomed (Lond). 2019;14(12):1565–78. · DOI
  125. Batooei S, et al. Metal-based nanoparticles as radio-sensitizer in gastric cancer therapy. J Drug Deliv Sci Technol. 2020;56:101576. · DOI
  126. Klebowski B, et al. Gold-Decorated Platinum and Palladium Nanoparticles as modern nanocomplexes to improve the effectiveness of simulated anticancer Proton Therapy. Pharmaceutics. 2021;13(10):1726. · DOI
  127. Javed B, Mashwani ZU. Synergistic effects of Physicochemical parameters on Bio-fabrication of Mint Silver nanoparticles: structural evaluation and action against HCT116 Colon Cancer cells. Int J Nanomedicine. 2020;15:3621–37. · DOI
  128. Spyridopoulou K, et al. Biogenic selenium nanoparticles produced by Lactobacillus casei ATCC 393 inhibit colon Cancer cell growth in vitro and in vivo. Nanoscale Adv. 2021;3(9):2516–28. · DOI
  129. Vigneshwaran R, Ezhilarasan D, Rajeshkumar S. Inorganic titanium dioxide nanoparticles induces cytotoxicity in colon Cancer cells. Inorg Chem Commun. 2021;133:108920. · DOI · Paper page
  130. Verma SK, et al. Mechanistic insight into size-dependent enhanced cytotoxicity of industrial antibacterial titanium oxide nanoparticles on colon cells because of reactive oxygen species quenching and Neutral lipid alteration. ACS Omega. 2018;3(1):1244–62. · DOI
  131. Chaturvedi VK et al. Pleurotus sajor-caju-mediated synthesis of silver and gold nanoparticles active against Colon Cancer cell lines: a new era of Herbonanoceutics. 2020. 25(13). · DOI
  132. Z AB, D SG. Rapid Delivery of Gold nanoparticles into Colon Cancer HT-29 cells by Electroporation: In-vitro study. J Biomed Phys Eng. 2020;10(2):161–6.
  133. González-Ballesteros N, et al. Macroalgae to nanoparticles: study of Ulva lactuca L. role in biosynthesis of gold and silver nanoparticles and of their cytotoxicity on colon Cancer cell lines. Mater Sci Eng C Mater Biol Appl. 2019;97:498–509. · DOI
  134. Malaikolundhan H et al. Anticarcinogenic effect of gold nanoparticles synthesized from Albizia lebbeck on HCT-116 colon Cancer cell lines. 2020. 48(1): p. 1206–13. · DOI
  135. Datkhile KD, et al. Biogenic synthesis of gold nanoparticles using Argemone mexicana L. and their cytotoxic and genotoxic effects on human colon Cancer cell line (HCT-15). J Genet Eng Biotechnol. 2021;19(1):9. · DOI
  136. Huang RF, et al. Inhibition of colon Cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene. Int J Nanomedicine. 2015;10:2823–46.
  137. Saberi A, et al. Gold nanoparticles in combination with megavoltage radiation energy increased radiosensitization and apoptosis in colon Cancer HT-29 cells. Int J Radiat Biol. 2017;93(3):315–23. · DOI
  138. Namasivayam SKR, et al. Molecular intervention of colon Cancer and inflammation manifestation by tannin capped biocompatible controlled sized gold nanoparticles from Terminalia bellirica: a green strategy for pharmacological drug formulation based on nanotechnology principles. 3 Biotech. 2021;11(9):401. · DOI
  139. Han X, et al. Anticarcinogenic potential of gold nanoparticles synthesized from Trichosanthes kirilowii in colon Cancer cells through the induction of apoptotic pathway. Artif Cells Nanomed Biotechnol. 2019;47(1):3577–84. · DOI
  140. Arya M et al. In vitro and in silico molecular interaction of multiphase nanoparticles containing inositol hexaphosphate and jacalin: Therapeutic potential against colon cancer cells (HCT-15) 2019. · DOI
  141. Akbarzadeh Khiavi M, Safary A. PEGylated gold nanoparticles-ribonuclease induced oxidative stress and apoptosis in Colorectal cancer cells. 2020. 10(1): p. 27–36. · DOI
  142. Sazgarnia A, et al. Therapeutic effects of acoustic cavitation in the presence of gold nanoparticles on a colon Tumor model. J Ultrasound Med. 2013;32(3):475–83. · DOI
  143. Javed B, Mashwani ZU. Synergistic effects of Physicochemical parameters on Bio-fabrication of Mint Silver nanoparticles: structural evaluation and action against HCT116 Colon Cancer cells. 2020. 15: p. 3621–37. · DOI
  144. Gurunathan S et al. Cytotoxic Potential and Molecular Pathway Analysis of Silver Nanoparticles in human Colon Cancer cells HCT116. 2018. 19(8). · DOI
  145. Saha S, et al. Gold nanoparticle reprograms pancreatic Tumor Microenvironment and inhibits Tumor Growth. ACS Nano. 2016;10(12):10636–51. · DOI
  146. Huai Y, et al. Gold nanoparticles sensitize Pancreatic cancer cells to gemcitabine. Cell Stress. 2019;3(8):267–79. · DOI
  147. Cutler JI, Auyeung E, Mirkin CA. Spherical nucleic acids. J Am Chem Soc. 2012;134(3):1376–91. · DOI
  148. Jensen SA, et al. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med. 2013;5(209):209ra152. · DOI · Paper page
  149. Randeria PS, et al. siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown. Proc Natl Acad Sci U S A. 2015;112(18):5573–8. · DOI
  150. Shajari N, et al. Overcoming the challenges of siRNA delivery: nanoparticle strategies. Curr Drug Deliv. 2017;14(1):36–46. · DOI
  151. Hao L, et al. Nucleic acid-gold nanoparticle conjugates as mimics of microRNA. Small. 2011;7(22):3158–62. · DOI
  152. Hosseinalizadeh H, Mahmoodpour M, Ebrahimi A. Circulating non-coding RNAs as a diagnostic and management biomarker for Breast cancer: current insights. Mol Biol Rep. 2022;49(1):705–15. · DOI
  153. Lei Y, et al. Gold nanoclusters-assisted delivery of NGF siRNA for effective treatment of Pancreatic cancer. Nat Commun. 2017;8:15130. · DOI
  154. Imanparast A, et al. Pegylated hollow gold-mitoxantrone nanoparticles combining photodynamic therapy and chemotherapy of cancer cells. Photodiagnosis Photodyn Ther. 2018;23:295–305. · DOI
  155. Qiu W, et al. Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in Pancreatic cancer. Int J Nanomedicine. 2018;13:6809–27. · DOI
  156. Zielinska E, et al. Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinoma. Oncotarget. 2018;9(4):4675. · DOI
  157. Ivošev V, et al. Uptake and excretion dynamics of gold nanoparticles in cancer cells and fibroblasts. Nanotechnology. 2020;31(13):135102. · DOI
  158. Huai Y, et al. Gold nanoparticles sensitize Pancreatic cancer cells to gemcitabine. Cell Stress. 2019;3(8):267. · DOI
  159. Roy I. Gold nanoparticle-enhanced photodynamic therapy from photosensitiser-entrapped ormosil nanoparticles. J Nanosci Nanotechnol. 2019;19(11):6942–8. · DOI
  160. Zhang F, et al. Interventional photothermal therapy enhanced brachytherapy: a new strategy to fight deep Pancreatic cancer. Adv Sci. 2019;6(5):1801507. · DOI
  161. Qiu W, et al. Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in Pancreatic cancer. Int J Nanomed. 2018;13:6809. · DOI
  162. Steckiewicz KP, et al. Assessment of Anti-tumor potential and safety of application of glutathione stabilized gold nanoparticles conjugated with Chemotherapeutics. Int J Med Sci. 2020;17(6):824. · DOI
  163. Elechalawar CK et al. Targeting Pancreatic Cancer cells and stellate cells using designer nanotherapeutics in vitro. 2020. 15: p. 991–1003. · DOI
  164. Patra CR, et al. Fabrication of gold nanoparticles for targeted therapy in Pancreatic cancer. Adv Drug Deliv Rev. 2010;62(3):346–61. · DOI
  165. Zielinska E, et al. Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinoma. Oncotarget. 2018;9(4):4675–97. · DOI
  166. Thandra KC, et al. Epidemiology of Lung cancer. Contemp Oncol (Pozn). 2021;25(1):45–52.
  167. He XX, et al. Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses Tumor properties. Oncol Rep. 2014;32(3):1200–10. · DOI
  168. Jin X, et al. CASC2/miR-24/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8/caspase-3. Cell Death Dis. 2018;9(3):318. · DOI
  169. Kim J, et al. miR-221 regulates CD44 in hepatocellular carcinoma through the PI3K-AKT-mTOR pathway. Biochem Biophys Res Commun. 2017;487(3):709–15. · DOI
  170. Colagrande S, et al. Challenges of advanced hepatocellular carcinoma. World J Gastroenterol. 2016;22(34):7645–59. · DOI
  171. Woo HY, Yoo SY, Heo J. New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails? Expert Opin Pharmacother. 2017;18(1):35–44. · DOI
  172. Ogasawara S, et al. Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment. Invest New Drugs. 2018;36(2):332–9. · DOI
  173. Cai H, et al. Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells. Int J Med Sci. 2019;16(12):1541–8. · DOI
  174. Ma X, et al. Enhanced immunotherapy of SM5-1 in hepatocellular carcinoma by conjugating with gold nanoparticles and its in vivo bioluminescence tomographic evaluation. Biomaterials. 2016;87:46–56. · DOI
  175. Trefzer U, et al. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions. Arch Dermatol Res. 2000;292(12):583–9. · DOI
  176. Ebrahim HM, et al. The synergistic cytotoxic effect of laser-irradiated gold nanoparticles and Sorafenib against the growth of a human Hepatocellular Carcinoma Cell line. Asian Pac J Cancer Prev. 2019;20(11):3369–76. · DOI
  177. Lu SL et al. Enhanced radiosensitization for Cancer Treatment with Gold nanoparticles through Sonoporation. Int J Mol Sci, 2020. 21(21). · DOI
  178. Choi K, Joo H. Assessment of Gold nanoparticles-inhibited cytochrome P450 3A4 activity and molecular mechanisms underlying its Cellular Toxicity in Human Hepatocellular Carcinoma Cell Line C3A. Nanoscale Res Lett. 2018;13(1):279. · DOI
  179. Lu SL, Liu WW. Enhanced Radiosensitization for Cancer Treatment with Gold Nanoparticles through Sonoporation 2020. 21(21). · DOI
  180. Mostafa SM, Gamal-Eldeen AM. Epigallocatechin gallate-capped gold nanoparticles enhanced the Tumor suppressors let-7a and miR-34a in hepatocellular carcinoma cells. 2020. 92(4): p. e20200574. · DOI
  181. Jha S, et al. Binding and uptake into human hepatocellular carcinoma cells of peptide-functionalized gold nanoparticles. Bioconjug Chem. 2017;28(1):222–9. · DOI
  182. Ebrahim HM, et al. The synergistic cytotoxic effect of laser-irradiated gold nanoparticles and Sorafenib against the growth of a human. Hepatocellular Carcinoma Cell Line. 2019;20(11):3369–76.
  183. Xue HY, et al. Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma. Oncotarget. 2016;7(52):86675–86. · DOI
  184. Meng WC, Pan Y, Zhao X. Epirubicin-gold nanoparticles suppress hepatocellular carcinoma xenograft growth in nude mice. J Biomed Res. 2015;29(6):486–90. · DOI
  185. Park SY et al. Anti-metastatic effect of gold nanoparticle-conjugated Maclura tricuspidata Extract on Human Hepatocellular Carcinoma cells. 2020. 15: p. 5317–31. · DOI
  186. Ahmadian E, et al. Effect of silver nanoparticles in the induction of apoptosis on human hepatocellular carcinoma (HepG2) cell line. Mater Sci Eng C Mater Biol Appl. 2018;93:465–71. · DOI
  187. Taha H, et al. Raptinal silver nanoparticles: new therapeutic advances in hepatocellular carcinoma mouse model. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(2):279–89. · DOI
  188. Cardinal J, et al. Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery. 2008;144(2):125–32. · DOI
  189. Gentili D, Ori G, Comes M, Franchini. Double phase transfer of gold nanorods for surface functionalization and entrapment into PEG-based nanocarriers. Chem Commun (Camb), 2009(39): p. 5874–6. · DOI
  190. Takahashi H, et al. Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity. Langmuir. 2006;22(1):2–5. · DOI
  191. Gobin AM, et al. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett. 2007;7(7):1929–34. · DOI
  192. Lowery AR, et al. Immunonanoshells for targeted photothermal ablation of Tumor cells. Int J Nanomedicine. 2006;1(2):149–54. · DOI
  193. O’Neal DP, et al. Photo-thermal Tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004;209(2):171–6. · DOI
  194. Day ES, et al. Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of Breast cancer. Int J Nanomedicine. 2010;5:445–54. · DOI
  195. Gobin AM, et al. Near infrared laser-tissue welding using nanoshells as an exogenous absorber. Lasers Surg Med. 2005;37(2):123–9. · DOI
  196. Gobin AM, Moon JJ, West JL. EphrinA I-targeted nanoshells for photothermal ablation of Prostate cancer cells. Int J Nanomedicine. 2008;3(3):351–8.
  197. Li Y, et al. Infrared light-absorbing gold/gold sulfide nanoparticles induce cell death in esophageal adenocarcinoma. Int J Nanomedicine. 2013;8:2153–61.
  198. Dastjerdi R, Montazer M. A review on the application of inorganic nano-structured materials in the modification of textiles: focus on anti-microbial properties. Colloids Surf B Biointerfaces. 2010;79(1):5–18. · DOI
  199. Delgado K, et al. Polypropylene with embedded copper metal or copper oxide nanoparticles as a novel plastic antimicrobial agent. Lett Appl Microbiol. 2011;53(1):50–4. · DOI
  200. Luo S, et al. A new method for fabricating a CuO/TiO2 nanotube arrays electrode and its application as a sensitive nonenzymatic glucose sensor. Talanta. 2011;86:157–63. · DOI

200 of 238 shown

Cited by

Sorted by citations

See all 84

Metadata

Authors
Roshani, M., Rezaian-Isfahni, A., Lotfalizadeh, M. H., Khassafi, N., Abadi, M. H. J. N., & Nejati, M.
Venue
Cancer Cell International
Published
2023-11-19
Volume
23
Issue
1
ISSN
1475-2867
Cited by
84
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review